Sarissa Capital Management LP Long-Term Concentrated

CIK: 0001577524 · Show all filings

Period: Q4 2014 (← Previous) (Next →)

Filing Date: Feb 17, 2015

Total Value ($000): $282,531 (100.0% shares, 0.0% debt)

Holdings (16)

— ARIAD PHARMACEUTICALS INC 31.2%

Value ($000) $88,280 Shares 12,850,000 Est. Cost $6.73 Unrealized —

DGX QUEST DIAGNOSTICS INC 18.4%

Value ($000) $51,972 Shares 775,000 Est. Cost $46.05 Unrealized +9.7%

AMGN AMGEN INC 17.9%

Value ($000) $50,654 Shares 318,000 Est. Cost $104.63 Unrealized +8.3%

MRK MERCK & CO INC NEW 8.0%

Value ($000) $22,716 Shares 400,000 Est. Cost $31.29 Unrealized +25.8%

A AGILENT TECHNOLOGIES INC. 6.7%

Value ($000) $18,832 Shares 460,000 Est. Cost $37.20 Unrealized -1.0%

— BIO-REFERENCE LABS INC 4.4%

Value ($000) $12,539 Shares 390,270 Est. Cost $27.20 Unrealized —

— REPROS THERAPEUTICS INC 4.0%

Value ($000) $11,290 Shares 1,132,367 Est. Cost $16.90 Unrealized —

— VIVUS INC 2.6%

Value ($000) $7,413 Shares 2,573,943 Est. Cost $9.08 Unrealized —

— INTRA CELLULAR THERAPIES INC 2.2%

Value ($000) $6,354 Shares 360,000 Est. Cost $16.06 Unrealized —

— KINDRED BIOSCIENCES INC 1.8%

Value ($000) $5,134 Shares 689,091 Est. Cost $11.56 Unrealized —

— AVEO PHARMACEUTICALS INC 0.8%

Value ($000) $2,160 Shares 2,570,759 Est. Cost $1.84 Unrealized —

ANIP ANI PHARMACEUTICALS INC 0.6%

Value ($000) $1,748 Shares 31,000 Est. Cost $44.09 Unrealized 0.0%

— TARGACEPT INC 0.6%

Value ($000) $1,657 Shares 630,000 Est. Cost $4.63 Unrealized —

— APRICUS BIOSCIENCES INC 0.4%

Value ($000) $1,030 Shares 1,030,000 Est. Cost $1.00 Unrealized —

— ELEVEN BIOTHERAPEUTICS INC. 0.2%

Value ($000) $489 Shares 41,200 Est. Cost $11.87 Unrealized —

— CYCLACEL PHARMACEUTICALS INC. 0.1%

Value ($000) $263 Shares 376,000 Est. Cost $0.70 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ARIAD PHARMACEUTICALS INC	12,850,000	$88,280	31.2%	$6.73	—	COM	04033A100
DGX	QUEST DIAGNOSTICS INC	775,000	$51,972	18.4%	$46.05	+9.7%	COM	74834L100
AMGN	AMGEN INC	318,000	$50,654	17.9%	$104.63	+8.3%	COM	031162100
MRK	MERCK & CO INC NEW	400,000	$22,716	8.0%	$31.29	+25.8%	COM	58933Y105
A	AGILENT TECHNOLOGIES INC.	460,000	$18,832	6.7%	$37.20	-1.0%	COM	00846U101
—	BIO-REFERENCE LABS INC	390,270	$12,539	4.4%	$27.20	—	COM $.01 NEW	09057G602
—	REPROS THERAPEUTICS INC	1,132,367	$11,290	4.0%	$16.90	—	COM NEW	76028H209
—	VIVUS INC	2,573,943	$7,413	2.6%	$9.08	—	COM	928551100
—	INTRA CELLULAR THERAPIES INC	360,000	$6,354	2.2%	$16.06	—	COM	46116X101
—	KINDRED BIOSCIENCES INC	689,091	$5,134	1.8%	$11.56	—	COM	494577109
—	AVEO PHARMACEUTICALS INC	2,570,759	$2,160	0.8%	$1.84	—	COM	053588109
ANIP	ANI PHARMACEUTICALS INC	31,000	$1,748	0.6%	$44.09	0.0%	COM	00182C103
—	TARGACEPT INC	630,000	$1,657	0.6%	$4.63	—	COM	87611R306
—	APRICUS BIOSCIENCES INC	1,030,000	$1,030	0.4%	$1.00	—	COM	03832V109
—	ELEVEN BIOTHERAPEUTICS INC.	41,200	$489	0.2%	$11.87	—	COM	286221106
—	CYCLACEL PHARMACEUTICALS INC.	376,000	$263	0.1%	$0.70	—	COM NEW	23254L306